It’s not at all clear what a tariff would mean for Novo, which manufactures its medicines in facilities all over the world, ...

The New York company is hoping to enter the GLP-1RA space with its newest offering requiring dosing every month over ...

Looking to expand its legacy in metabolic conditions, Novo Nordisk has inked a multiyear research pact with Variant Bio to better understand the genetics underlying disease across diverse populatio | ...

Variant Bio, a small biotech company based in Seattle, is using genetic information from Indigenous people to develop drugs ...

While obesity product sales will be driving the boon in 2025, industry experts are also eyeing promising new launches in ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...